loading

Bristol Myers Squibb Co (BMY) 最新ニュース

pulisher
08:10 AM

John G Ullman & Associates Inc. Decreases Stake in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

08:10 AM
pulisher
08:00 AM

Is Bristol Myers Squibb Stock a Buy? - The Motley Fool

08:00 AM
pulisher
07:36 AM

Primecap Management Co. CA Has $1.21 Billion Stock Holdings in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

07:36 AM
pulisher
05:38 AM

Commerce Bank Sells 30,241 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

05:38 AM
pulisher
05:12 AM

77,494 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by B. Metzler seel. Sohn & Co. Holding AG - MarketBeat

05:12 AM
pulisher
Nov 20, 2024

Vital Signs: Merck maps Keytruda's next act in the injectables marketplace - FirstWord Pharma

Nov 20, 2024
pulisher
Nov 20, 2024

Psoriasis Market is expected to rise at a significant CAGR, DelveInsight | Hangzhou Highlightll Pharmaceutical Co., Ltd, Biohaven Pharmaceuticals, Inc., SFA Therapeutics, Bristol-Myers Squibb - Barchart

Nov 20, 2024
pulisher
Nov 20, 2024

Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Nov 20, 2024
pulisher
Nov 20, 2024

Premier Fund Managers Ltd Takes Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

CAMZYOS™ Honoured with the Prix Galien Canada Innovative Product Award - cnhinews.com

Nov 20, 2024
pulisher
Nov 19, 2024

GLP-1 Analogues Market Outlook: Rapid Growth at 21.3% CAGR to Surpass USD 322.85 Billion by 2034 | PMR - GlobeNewswire Inc.

Nov 19, 2024
pulisher
Nov 19, 2024

BRISTOL-MYERS SQUIBB CANADA WINS THE 2024 PRIX GALIEN INNOVATIVE PRODUCT AWARD - Barchart

Nov 19, 2024
pulisher
Nov 19, 2024

Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch

Nov 19, 2024
pulisher
Nov 19, 2024

J&J, Protagonist's oral psoriasis prospect scores in phase 3 pair, readying case against BMS' Sotyktu - Fierce Biotech

Nov 19, 2024
pulisher
Nov 19, 2024

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by PNC Financial Services Group Inc. - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

BMS CFO backs “resilient” pharma industry amid RFK’s impending governance - Pharmaceutical Technology

Nov 19, 2024
pulisher
Nov 19, 2024

OneAscent Financial Services LLC Purchases Shares of 8,855 Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Why Bristol Myers Squibb is a Top 25 Dividend Giant (BMY) - Nasdaq

Nov 19, 2024
pulisher
Nov 19, 2024

Bristol Myers to Present 90+ Studies at ASH, Including 5-Year Breyanzi Data | BMY Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Natixis Advisors LLC - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases - Benzinga

Nov 18, 2024
pulisher
Nov 18, 2024

Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now? - Insider Monkey

Nov 18, 2024
pulisher
Nov 18, 2024

EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer - Pharmaceutical Technology

Nov 18, 2024
pulisher
Nov 17, 2024

Bristol-Myers Squibb: Buy This Bargain Stock Before It's Gone (NYSE:BMY) - Seeking Alpha

Nov 17, 2024
pulisher
Nov 17, 2024

Swiss National Bank Boosts Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

Kinsale Capital Group Inc. Purchases 18,163 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Mizuho Markets Americas LLC Lowers Holdings in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Kentucky Retirement Systems Lowers Stake in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Bristol-Myers Squibb (NYSE:BMY) Trading Down 3%Here's Why - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer - BioSpace

Nov 15, 2024
pulisher
Nov 15, 2024

Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue - Benzinga

Nov 15, 2024
pulisher
Nov 15, 2024

EU regulators endorse meds from BMS, J&J, Eisai and more—plus a clutch of biosims - FiercePharma

Nov 15, 2024
pulisher
Nov 15, 2024

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Sheaff Brock Investment Advisors LLC - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

BMYBristol-Myers Squibb Co. Latest Stock News & Market Updates - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

Cornercap Investment Counsel Inc. Reduces Holdings in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Bristol-Myers Squibb (NYSE:BMY) Now Covered by Analysts at Wolfe Research - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Celgene Shareholders Hit BMS with Fresh Lawsuit for Allegedly Dodging CVR Payments - BioSpace

Nov 15, 2024
pulisher
Nov 15, 2024

Bristol Myers' Cancer Drug Repotrectinib Gains Key EU Panel Backing for Lung Cancer | BMY Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

The Bristol Myers Squibb Foundation - Bristol Myers Squibb

Nov 15, 2024
pulisher
Nov 14, 2024

Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug - Reuters

Nov 14, 2024
pulisher
Nov 14, 2024

Justice on the Move: The Impact of Bristol-Myers Squibb on FLSA Forum-Shopping - The National Law Review

Nov 14, 2024
pulisher
Nov 14, 2024

9,269 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by Sargent Investment Group LLC - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Bristol-Myers Squibb Company's (NYSE:BMY) high institutional ownership speaks for itself as stock continues to impress, up 5.7% over last week - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Bristol-Myers Squibb (NYSE:BMY) Stake Lessened by KBC Group NV - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Plato Investment Management Ltd Purchases 13,447 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Clinical trials & studies - Bristol Myers Squibb

Nov 14, 2024
pulisher
Nov 13, 2024

Bristol Myers Squibb showcases cardiovascular portfolio at AHA Scientific Sessions 2024 - Indian Pharma Post

Nov 13, 2024
pulisher
Nov 13, 2024

ICICI Prudential Asset Management Co Ltd Sells 38,500 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Is Bristol-Myers Squibb Company (BMY) Among The Top Dividend Contenders Right Now? - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Oppenheimer & Co. Inc. Raises Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink - FiercePharma

Nov 13, 2024
pulisher
Nov 13, 2024

Pinnacle Financial Partners Inc Acquires 272,439 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Mengis Capital Management Inc. Has $3.37 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Aigen Investment Management LP Sells 102,823 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Equities Analysts Issue Forecasts for BMY Q4 Earnings - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Bristol-Myers Squibb (NYSE:BMY) Upgraded by Leerink Partnrs to "Strong-Buy" Rating - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day - MarketWatch

Nov 12, 2024
pulisher
Nov 12, 2024

Bristol-Myers Squibb (NYSE:BMY) Price Target Raised to $60.00 at Citigroup - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga

Nov 12, 2024
pulisher
Nov 12, 2024

Bristol-Myers Squibb's $14 Billion PotentialAnalyst Upgrades Stock - Benzinga

Nov 12, 2024
pulisher
Nov 12, 2024

BMO Capital Markets Boosts Bristol-Myers Squibb (NYSE:BMY) Price Target to $61.00 - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

AbbVie’s loss is Bristol Myers Squibb’s gainanalyst - Proactive Investors USA

Nov 12, 2024
pulisher
Nov 12, 2024

American Assets Inc. Purchases New Holdings in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 12, 2024
drug_manufacturers_general SNY
$47.95
price up icon 0.37%
drug_manufacturers_general PFE
$25.12
price up icon 0.72%
$290.00
price up icon 0.60%
drug_manufacturers_general NVS
$103.85
price up icon 0.72%
drug_manufacturers_general MRK
$99.47
price up icon 2.05%
大文字化:     |  ボリューム (24 時間):